CUSIP: 589331107
Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
621,925
-
Share change
-
-1,408
-
Total reported value
-
$67,987,260
-
Price per share
-
$109.02
-
Number of holders
-
11
-
Value change
-
-$159,223
-
Number of buys
-
1
-
Number of sells
-
6
Security key
589331107
Report period
Q4 2023
Institutions
11
Top holders
10
Reporting periods
Holder history for CUSIP 589331107
Recent filing periods:
Top shareholders of 589331107 - Merck & Co Inc - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Merck & Co Inc - COM as of Q4 2023
As of 31 Dec 2023,
Merck & Co Inc - COM was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
621,925 shares.
The largest 10 holders included
Bruce & Co., Inc., Cohen Klingenstein LLC, Grassi Investment Management, Ironwood Investment Counsel, LLC, Curbstone Financial Management Corp, West Oak Capital, LLC, Blue Edge Capital, LLC, Opus Capital Group, LLC, WEDGEWOOD INVESTORS INC /PA/, and AlphaMark Advisors, LLC.
This page lists
11
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
Compare Q4 2023 vs Q3 2023 Across Filers
| Investor |
Q3 2023 Shares |
Q4 2023 Shares |
Share Diff |
Share Chg % |
Q3 2023 Value $ |
Q4 2023 Value $ |
Value Diff $ |
Value Chg % |
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.